HK1131806A1 - Biomarkers for prostate cancer and methods using the same - Google Patents

Biomarkers for prostate cancer and methods using the same

Info

Publication number
HK1131806A1
HK1131806A1 HK09110767.1A HK09110767A HK1131806A1 HK 1131806 A1 HK1131806 A1 HK 1131806A1 HK 09110767 A HK09110767 A HK 09110767A HK 1131806 A1 HK1131806 A1 HK 1131806A1
Authority
HK
Hong Kong
Prior art keywords
biomarkers
prostate cancer
methods
same
suites
Prior art date
Application number
HK09110767.1A
Other languages
English (en)
Inventor
Matthew W Mitchell
Kay A Lawton
Alvin Berger
Chris Beecher
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of HK1131806A1 publication Critical patent/HK1131806A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Cosmetics (AREA)
HK09110767.1A 2006-09-19 2009-11-17 Biomarkers for prostate cancer and methods using the same HK1131806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84560006P 2006-09-19 2006-09-19
PCT/US2007/078805 WO2008036691A2 (fr) 2006-09-19 2007-09-18 Biomarqueurs du cancer de la prostate et procédés les utilisant

Publications (1)

Publication Number Publication Date
HK1131806A1 true HK1131806A1 (en) 2010-02-05

Family

ID=39201218

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110767.1A HK1131806A1 (en) 2006-09-19 2009-11-17 Biomarkers for prostate cancer and methods using the same

Country Status (7)

Country Link
US (2) US8518650B2 (fr)
EP (3) EP2061899B1 (fr)
JP (1) JP5297379B2 (fr)
AU (1) AU2007299846B2 (fr)
CA (1) CA2662655A1 (fr)
HK (1) HK1131806A1 (fr)
WO (1) WO2008036691A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008016111A1 (fr) 2006-08-04 2008-02-07 Ajinomoto Co., Inc. Procédé permettant d'évaluer un cancer du poumon, dispositif d'évaluation d'un cancer du poumon, procédé d'évaluation d'un cancer du poumon, système d'évaluation d'un cancer du poumon, programme d'évaluation d'
JP5297379B2 (ja) 2006-09-19 2013-09-25 メタボロン、インコーポレイテッド 前立腺癌のバイオマーカー及びそれを使用する方法
EP2103940A4 (fr) 2006-12-21 2013-04-24 Ajinomoto Kk Procédé, appareil, procédé, système et logiciel d'évaluation du cancer du sein, et support d'enregistrement
WO2008075663A1 (fr) 2006-12-21 2008-06-26 Ajinomoto Co., Inc. Procédé, appareil, procédé, système et logiciel d'évaluation du cancer colorectal, et support d'enregistrement
US20090047269A1 (en) * 2007-08-16 2009-02-19 The Regents Of The University Of Michigan Metabolomic cancer targets
KR20110003464A (ko) * 2008-01-31 2011-01-12 각고호우징 게이오기주크 항암제 감수성 판정 마커
WO2009109798A2 (fr) * 2008-03-07 2009-09-11 Universität Ulm Précurseurs du métabolisme lipidique pour le diagnostic et le traitement du cancer
WO2009154297A1 (fr) * 2008-06-20 2009-12-23 味の素株式会社 Procédé d'évaluation d’une maladie prostatique
WO2009154296A1 (fr) * 2008-06-20 2009-12-23 味の素株式会社 Procédé d'évaluation de cancer génital chez la femme
EP3296743A1 (fr) * 2009-06-04 2018-03-21 Metanomics Health GmbH Procédés de diagnostic de carcinomes de la prostate
CN105891317B (zh) * 2009-10-30 2019-08-09 学校法人庆应义塾 抗癌剂感受性判定标记
WO2011087845A2 (fr) * 2009-12-22 2011-07-21 The Regents Of The University Of Michigan Profilage métabolomique du cancer de la prostate
CA2807811A1 (fr) * 2010-07-28 2012-02-02 Metabolon Inc. Biomarqueurs du cancer de la prostate et procedes les utilisant
WO2012127984A1 (fr) * 2011-03-24 2012-09-27 学校法人慶應義塾 Marqueur pour la détermination de la sensibilité à un agent anticancéreux
CA2853202A1 (fr) * 2011-12-09 2013-06-13 Metabolon, Inc. Biomarqueurs pour cancer renal et leurs procedes d'utilisation
JP6141824B2 (ja) 2012-02-23 2017-06-07 学校法人慶應義塾 併用抗がん剤の感受性判定マーカー
CN104021264B (zh) 2013-02-28 2017-06-20 华为技术有限公司 一种缺陷预测方法及装置
GB201419976D0 (en) * 2014-11-10 2014-12-24 Univ Newcastle Biomarkers for disease progression in melanoma
CN105934672A (zh) * 2014-12-22 2016-09-07 J制药股份有限公司 癌症的血中生物标记
US9858665B2 (en) 2015-04-03 2018-01-02 Regents Of The University Of Minnesota Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models
CA3030219A1 (fr) * 2016-07-07 2018-01-11 Berg Llc Marqueurs lipidiques, proteiques et metaboliques pour le diagnostic et le traitement du cancer de la prostate
US10588884B2 (en) * 2016-11-01 2020-03-17 Duke University Modulators of prostate-specific G-protein receptor (PSGR/OR51E2) and methods of using same
CN106770873B (zh) * 2017-01-19 2019-02-19 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
CN108383910B (zh) * 2018-02-12 2021-06-11 济南泰和医药科技有限公司 一种识别单羟酚类化合物的单克隆抗体及其制备方法和应用
KR102405789B1 (ko) * 2018-08-24 2022-06-07 고려대학교 세종산학협력단 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물
US11633146B2 (en) 2019-01-04 2023-04-25 Regents Of The University Of Minnesota Automated co-registration of prostate MRI data
US11631171B2 (en) 2019-01-10 2023-04-18 Regents Of The University Of Minnesota Automated detection and annotation of prostate cancer on histopathology slides
CN109991342B (zh) * 2019-03-08 2022-02-15 首都医科大学附属北京同仁医院 一种诊断或预防糖尿病视网膜病变的生物标志物、检测试剂及用途
WO2021049862A1 (fr) * 2019-09-10 2021-03-18 고려대학교 세종산학협력단 Marqueur de diagnostic du cancer de la prostate contenant de l'indoléamine 2,3-dioxygénase
WO2021158720A1 (fr) * 2020-02-05 2021-08-12 The Cleveland Clinic Foundation Détection et traitement de maladie, basés sur des niveaux de phénylacétylglutamine
CN113440533B (zh) * 2021-07-01 2022-02-01 江南大学 水苏糖在制备用于治疗去势抵抗性前列腺癌药物中的应用
CN114200121A (zh) * 2021-12-15 2022-03-18 广州市番禺区中心医院(广州市番禺区人民医院、广州市番禺区心血管疾病研究所) 一种前列腺炎相关标志物及试剂盒
CN114487216A (zh) * 2022-01-27 2022-05-13 广州市番禺区中心医院 一种区分前列腺炎和前列腺癌的生物标志物及诊断试剂盒
CN114527222A (zh) * 2022-02-22 2022-05-24 广州市番禺区中心医院 前列腺癌相关标志物及其应用
CN115629214B (zh) * 2022-12-21 2023-03-10 北京大学第三医院（北京大学第三临床医学院） 一种用于卵巢癌早期诊断的生物标志物及其应用
CN116808243B (zh) * 2023-08-15 2024-04-02 上海交通大学 苯基-β-D-葡糖苷酸在制备用于诱导式呼气检测肿瘤的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020139A (en) 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
WO1999050437A1 (fr) 1998-03-30 1999-10-07 Esa, Inc. Methodologie permettant de prevenir et de diagnostiquer une maladie
US6866837B2 (en) 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
EP1285092A4 (fr) 2000-04-14 2003-07-16 Metabolon Inc Procedes permettant de decouvrir des medicaments, de traiter des maladies et de poser des diagnostics a l'aide de la metabolomique
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP1575420A4 (fr) * 2002-05-10 2007-12-26 Eastern Virginia Med School Biomarqueurs du cancer de la prostate
US20050181375A1 (en) 2003-01-10 2005-08-18 Natasha Aziz Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
EP1665108A2 (fr) * 2003-08-20 2006-06-07 BG Medicine, Inc. Methodes et systemes permettant de profiler des systemes biologiques
US20050048499A1 (en) * 2003-08-29 2005-03-03 Perkin Elmer Life Sciences, Inc. Tandem mass spectrometry method for the genetic screening of inborn errors of metabolism in newborns
US20070078093A1 (en) 2003-10-16 2007-04-05 The Administrators Of The Tulane Educational Fund Methods and compositions for treating cancer
US20070055456A1 (en) 2005-08-31 2007-03-08 Daniel Raftery NMR method for differentiating complex mixtures
EP1998789A4 (fr) * 2006-02-28 2009-04-22 Metabolon Inc Biomarqueurs pour sclérose latérale amyotrophique
WO2007109881A1 (fr) 2006-03-24 2007-10-04 Phenomenome Discoveries Inc. Biomarqueurs utiles pour diagnostiquer un cancer de la prostate et procédé d'utilisation de ceux-ci
US20090075284A1 (en) 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
JP5297379B2 (ja) 2006-09-19 2013-09-25 メタボロン、インコーポレイテッド 前立腺癌のバイオマーカー及びそれを使用する方法
US20090047269A1 (en) 2007-08-16 2009-02-19 The Regents Of The University Of Michigan Metabolomic cancer targets

Also Published As

Publication number Publication date
EP2560006A3 (fr) 2013-06-12
US20130309697A1 (en) 2013-11-21
AU2007299846B2 (en) 2014-11-20
US20100292331A1 (en) 2010-11-18
EP2560006A2 (fr) 2013-02-20
EP2061899B1 (fr) 2012-08-29
JP2010504527A (ja) 2010-02-12
AU2007299846A1 (en) 2008-03-27
EP2061899A2 (fr) 2009-05-27
WO2008036691A3 (fr) 2008-11-06
US8518650B2 (en) 2013-08-27
JP5297379B2 (ja) 2013-09-25
EP2657705A2 (fr) 2013-10-30
CA2662655A1 (fr) 2008-03-27
WO2008036691A2 (fr) 2008-03-27
EP2657705A3 (fr) 2013-12-25
EP2061899A4 (fr) 2010-06-16

Similar Documents

Publication Publication Date Title
HK1131806A1 (en) Biomarkers for prostate cancer and methods using the same
WO2013086365A3 (fr) Biomarqueurs pour cancer rénal et leurs procédés d'utilisation
HK1250521A1 (zh) 分析細胞增殖性病症的方法和核酸
WO2008039769A3 (fr) Procédés et dispositifs pour analyser de petites molécules d'arn
GB0612649D0 (en) No title
WO2010045318A3 (fr) Cibles géniques et protéiques exprimées par des gènes représentant des profils de biomarqueurs et des jeux de signatures par type de tumeurs
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
WO2008148072A3 (fr) Variations genetiques liees a une maladies et methodes de detection et d'utilisation de ces variations
EP2598873A4 (fr) Biomarqueurs du cancer de la prostate et procédés les utilisant
WO2007095644A3 (fr) reactifs et procedes pour le pronostic et la stadification pathologique d'un cancer
WO2007016548A3 (fr) Procedes et compositions a base de micro-arn pour le diagnostic, le pronostic et le traitement du cancer du sein
WO2006095086A8 (fr) Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence.
WO2007039290A3 (fr) Methodes et acides nucleiques pour l'analyse d'expression genique associee au pronostic de troubles de proliferation cellulaire
BRPI0716944A2 (pt) biomarcadores de modulaÇço alvo, eficÁcia, diagnàstico, e/ou prognàstico para inibidores de raf
WO2007030531A3 (fr) Reactifs d'essai et d'imagerie moleculaire du cancer du foie
DK2024747T3 (da) Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer
DK2258871T3 (da) Fremgangsmåder og nukleinsyrer til analyse af celleproliferative lidelser
ZA200710910B (en) Methods for the assessment of risk of developing lung cancer using analysis of genetic polymorphisms
WO2009085196A8 (fr) Procédés et compositions pour corréler des marqueurs génétiques avec un risque de cancer de la prostate
MX2009004382A (es) Variaciones geneticas asociadas con tumores.
WO2009058331A3 (fr) Biomarqueurs permettant la détection du cancer des ovaires à un stade précoce
WO2008104984A3 (fr) Diagnostic et pronostic de divers types de cancers
WO2004113574A3 (fr) Methodes de depistage d'une maladie
EP2151496A4 (fr) Procede d'evaluation de la sensibilite aux medicaments par analyse d'un gene pomc
MX2019002932A (es) Biomarcadores proteicos para enfermedades asociadas con el sistema de activacion por contacto.

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: ADDITION OF INVENTOR: BEECHER, CHRIS